Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spinraza
Pharma
Biogen CEO plots turnaround after 'weak' 2023 performance
While Biogen’s financials are in rough shape now, the company’s CEO, Chris Viebacher, sees reason to be optimistic about the future.
Fraiser Kansteiner
Feb 13, 2024 11:28am
Biogen pays $7.3B to acquire Reata and newly approved Skyclarys
Jul 28, 2023 11:17am
Reduction of 1,000 jobs will cut Biogen's workforce by 11.5%
Jul 25, 2023 11:05am
Biogen's new CEO looks to ads to boost new drugs
Feb 16, 2023 9:10am
Biogen bets $10M on implant to improve delivery of Spinraza
Jan 10, 2023 7:25am
6 pharmas hit by serious drug marketing breaches including Novo
Dec 12, 2022 1:01pm